Triptorelin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Triptorelin and local guidelines before prescribing.
GnRH analogue
Mechanism
GnRH agonist.
Uses
Prostate cancer, endometriosis, central precocious puberty, gender-affirming care.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hot flushes, tumour flare, reduced bone density, injection-site reaction.
Interactions
QT-prolonging drugs.
Contraindications and cautions
Pregnancy
Monitoring
PSA, bone density
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Antiandrogen cover for flare in prostate cancer.
More from the textbook: uses, cautions and other points
- GnRH agonists (goserelin, leuprorelin, triptorelin) - prostate and breast cancer, endometriosis, fibroids, precocious puberty; initial testosterone flare (cover with an anti-androgen such as bicalutamide in prostate cancer - can cause cord compression or urinary obstruction otherwise); then hot flushes, osteoporosis, loss of libido. …
Endocrine: Anatomy Physiology and Pharmacology - Treatment - GnRH agonist (e.g. leuprorelin, triptorelin) to pause central puberty; treat the underlying cause.
Paediatrics: Growth, development and nutrition - GnRH agonist (leuprorelin, triptorelin) | Central precocious puberty.
Paediatrics: Growth, development and nutrition
Where it is discussed in the book
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Paediatrics: Growth, development and nutrition (2 mentions)
- Integrated paediatrics chapter (2 mentions)